Tian'an Technology Group Ltd. is a holding company engaged in the research, development, manufacture, and commercialization of graphene-based health physiotherapy equipment and power control system solutions. The company operates through two primary business divisions: Health and Wellness Technology and Electric Vehicle Power Control Systems. In its healthcare segment, the company provides graphene far-infrared thermotherapy products designed for personal wellness, recovery, and rehabilitation, utilizing far-infrared thermal radiation between 6 and 14 micrometers. Its wellness product portfolio includes portable wearable devices, such as graphene-heated neck protectors, lumbar waist supports, and joint wraps; residential and commercial thermal therapy equipment, comprising graphene far-infrared energy rooms, thermal therapy mattresses, and full-body physiotherapy cabins; and associated smart temperature-control accessories. In its power control segment, the company provides electronic drive systems and components for low-speed electric vehicles, offering brushless direct current motor controllers; integrated electronic power management assemblies; drive system diagnostic units; and technical engineering and system integration services for electric forklifts, golf carts, municipal street sweepers, and specialty utility vehicles. Tian'an Technology Group Ltd. distributes its products and services to medical rehabilitation facilities, wellness clinics, commercial operators, electric vehicle manufacturers, and direct consumers primarily across mainland China. Founded in 2021 and headquartered in Shanghai, China, the company conducts its operations through subsidiaries including Shanghai Qige Power Technology Co., Ltd. and Tian'an Technology Group (HK) Limited. Recent company developments include the establishment of Henan Qige Power Artificial Intelligence Technology Co., Ltd. in September 2024 to integrate artificial intelligence solutions into its hardware and health technology systems; the strategic expansion and commercialization of its graphene-based therapeutic product lines alongside legacy motor control operations; the reorganization of its overseas corporate holding structure; and the quotation and regulatory reporting of its ordinary shares on the U.S. OTCQB market under the ticker symbol TANAF.